Speaker Profile

MD, Co-Founder and CEO, DoMore Diagnostics

Biography
Torbjørn is an experienced executive with a broad background within life sciences. He has practiced as a physician in radiology and sports medicine, and transitioned into business as a management consultant at McKinsey Company, where he served several pharma and healthcare clients. After McKinsey he joined pharma and biotech companies in Aker and eventually became EVP Innovation at Aker BioMarine, where he established and led the innovation department. Prior to DoMore Diagnostics, his latest positions were CFO at listed immunooncology companiesTargovax and Lytix Biopharma.


Talk
Personalized Cancer Treatment with AI Pathology Solutions
There is a large medical need to identify patients with resectable colorectal cancer at high risk who will benefit from chemotherapy. DoMore Diagnostics' Histotype Px is a digital biomarker developed with AI based on routine histology slides and can optimize treatement for 250 000 patients and save up to $4B in healthcare costs globally.


Clinical Dx Showcase:
DoMore Diagnostics

DoMore Diagnostics utilizes the power of AI to guide personalized cancer treatment decisions. Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II/III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgery.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 9.30 A.M.-1.45 P.M.,Showcase Track S2 - January 25 9.00 A.M.-4.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-2.45 P.M.


The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUN. 20TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required